Ludwig Institute for Cancer Research

Latest stories

26d
News-Medical-Net
Ludwig, CRI launch Phase 1/2 trial of combination immunotherapy for advanced ovarian cancerimmunotherapy for advanced ovarian cancer. The international, multicenter trial
Ludwig, CRI launch Phase 1/2 trial of combination immunotherapy for advanced ovarian cancer
News-Medical-Net / Posted 26 days ago
immunotherapy for advanced ovarian cancer. The international, multicenter trial is led by George Coukos, director of the Ludwig Institute for Cancer Research, Lausanne and Brad Monk, director of Gynecologic Oncology at St. Joseph's Hospital and... Read more
3 related stories

People in this news